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Using shotgun metagenomics, we identified an imported 
case of multidrug-resistant Mycobacterium leprae in a 
Filipino resident of Saudi Arabia in 2017. We determined 
the phylogenomic lineage (3K1) and identified mutations 
in rpoB and rrs corresponding to the multidrug-resistance 
phenotype clinically observed. Metagenomics sequencing 
can be used to identify multidrug-resistant M. leprae.
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Leprosy is a chronic dermatologic and neurologic disease caused by the infectious agent Mycobacte-
rium leprae and can lead to severe disabilities; >200,000 
new cases are reported annually worldwide, accord-
ing to the World Health Organization. A total of 242 
leprosy cases were reported in Saudi Arabia during 
2003–2012; however, little is known about the sub-
types and prevalence of drug resistance among these 
M. leprae cases (1).
In May 2017, a 30-year-old woman from the Phil-
ippines sought treatment at the dermatology clinic 
of King Fahad Medical City (KFMC) Hospital in Ri-
yadh, Saudi Arabia, for painful systemic skin nod-
ules and joint pain without joint swelling. She had no 
medical history of leprosy. The initial clinical diag-
nosis of this patient was inconclusive, but her initial 
signs and symptoms were suggestive of a connective 
tissue disease such as systemic lupus erythematosus, 
and initial clinical improvement was recorded after a 
short course of empiric steroids and hydroxychloro-
quine treatment. Other suspected diagnoses included 
lepromatous leprosy with type 2 erythema nodosum 
leprosum reaction or other nontuberculosis mycobac-
terial infection.
We performed a punch skin biopsy of the ex-
tensor surface of the forearm and performed Ziehl-
Neelsen staining; we observed a florid histiocytic 
1These senior authors contributed equally to this article.
proliferation containing numerous Mycobacterium ba-
cilli without an obvious granuloma (Appendix Figure 
1, https://wwwnc.cdc.gov/EID/article/26/3/19-
0661-App1.pdf). We referred the patient to the infec-
tious disease clinic, which performed QuantiFERON-
TB Gold (QIAGEN, https://www.quantiferon.com) 
and took a biopsy for bacterial and fungal culture, 
and all test results were negative. Mycobacterial cul-
ture showed >9 acid-fast bacilli/high-power field on 
smears, and no growth was observed on Lowenstein-
Jensen slants after 8 weeks of incubation.
Her treatment started with a daily regimen of 
clofazimine (50 mg), dapsone (100 mg), and rifampin 
(600 mg). Treatment with moxifloxacin (400 mg/d) 
and macrolides was briefly added (clarithromycin 
and azithromycin were both stopped because of gas-
trointestinal side effects) in case of possible nontu-
berculosis mycobacterial infection. The patient had 
multiple relapses during 12 months of follow-up and 
became steroid dependent (i.e., her skin lesions reap-
peared shortly after steroid treatment ended).
Because initial test reports were inconclusive and 
the etiologic agent was unconfirmed, we attempted to 
confirm the etiology by subjecting the patient’s skin 
biopsy sample to metagenomic sequencing; a DNA 
sequencing protocol without target DNA–enrich-
ment steps (2) was needed to unambiguously iden-
tify the etiologic agent. From the metagenomics data-
sets, we reconstructed the near-complete genome of 
the M. leprae species (which we named KFMC-1) at 
99.2% completeness when compared with M. leprae 
TN, a strain commonly used for reference (3). We as-
sembled the 3.24-Mb genome of M. leprae KFMC-1 in 
19 DNA segments, and average coverage was 20.02× 
(Appendix Table 1, Figure 2, panel A). A single-nucle-
otide polymorphism comparison of M. leprae KFMC-1 
with a globally representative set of M. leprae revealed 
KFMC-1 was most closely related to 3K1 Ryukyu-2 
(Appendix Figure 2, panel B), which was originally 
isolated in Japan (4). 
We identified 158 polymorphic sites in the ge-
nome (Appendix Table 2), which corresponded to 
136 single-nucleotide polymorphisms and 22 inser-
tion/deletions. In total, 53 of the 158 changes were 
new, and 63 appeared within gene-coding regions, 
a couple of which helped us predict the multidrug-
resistance profile. We identified a G→T nucleotide 
change, which leads to a nonsynonymous change 
(Q438H) in the rpoB gene (Appendix Figure 2, panel 
C). This substitution results in rifampin resistance (5), 
matching our clinical records. The C1414A mutation 
in the rrs locus is predicted to confer capreomycin re-
sistance, as observed previously in M. tuberculosis (6). 
After we confirmed the clinical diagnosis as an M. 
leprae infection, we halted moxifloxacin treatment and 
kept the patient on 3 standard antimicrobial drugs 
(clofazimine, dapsone, and rifampin). Afterward, the 
patient left Saudi Arabia and continued her antimi-
crobial drug course in her country of origin.
The predominant genotypes of M. leprae strains 
in the Middle East are subtypes 2 and 3 (7). Most 
3K cases are found in countries of East Asia, such 
as China (8), Japan (9), Korea (2), and the Philip-
pines (8). In addition, >37% of the leprosy cases in 
Saudi Arabia occur in persons from other countries 
(1). Our results suggest that this case of leprosy 
was imported from the patient’s country of origin. 
Saudi Arabia hosts a massive number of expatriates 
from all over the world, including persons from M. 
leprae–endemic countries, and also hosts one of the 
largest recurring religious gatherings in the world. 
Therefore, genomics-guided infection control ef-
forts are needed to monitor the potential importa-
tion and prevent the spread of M. leprae infections 
in the region.
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Melioidosis, caused by the telluric gram-negative rod Burkholderia pseudomallei, is endemic in 
Southeast Asia and northern Australia (1) but may be 
underdiagnosed in other tropical regions (2). Increas-
ing occurrences have been reported in the Caribbean 
during the past few decades among persons with 
no exposure to known endemic areas (3–5). Tropical 
environmental conditions and the presence of this 
bacterium in soil samples in the Caribbean support 
the plausibility of endemicity (3). We describe 3 new 
cases detected in Guadeloupe during 2016–2017.
Patient 1 was a 54-year-old man, receiving renal 
replacement therapy, with a history of hypertensive 
vascular nephropathy. He developed a pulmonary 
form of melioidosis in November 2016. Thoracoab-
dominal computed tomography (CT) scan showed 
bilateral nodular lesions. B. pseudomallei grew from 
bronchoalveolar lavage fluid obtained by fiberoptic 
bronchoscopy. Treatment with ceftazidime (6 g/d 
intravenously) was given for 2 weeks and switched 
to trimethoprim/sulfamethoxazole (TMP/SMX) 
(320/1,600 mg 2×/d orally) for 1 month, then changed 
to doxycycline because rash developed. The patient 
complied poorly with treatment; he died in March 
2017 under unknown circumstances.
Patient 2 was a 66-year-old woman with a his-
tory of arterial hypertension and diabetes mellitus, a 
subcutaneous abscess in the prepubic area surgically 
treated without microbiological identification (June 
2016), a lumbar hematoma (March 2017), and bactere-
mic obstructive pyelonephritis caused by Escherichia 
coli (April 2017). In April 2017, she developed a severe 
and disseminated form of melioidosis with pneumo-
nia, bacteremia, and deep abscess. CT scan showed 
multiple pulmonary nodes consistent with hematog-
enous pneumonia, a deep abscess between kidney 
and psoas, and splenic emboli. B. pseudomallei was 
isolated from blood cultures performed at admission 
and from the abscess. The patient developed multiple 
complications: acute respiratory distress syndrome, 
systemic candidiasis, renal failure, hemodynamic 
failure, nonspecific encephalopathy, refractory sep-
tic shock related to catheter infection, and bacteremia 
caused by extended spectrum β-lactamase Klebsiella 
pneumoniae. In the intensive care unit, she was treated 
with ceftazidime (6 g/d for 24 d), then with merope-
nem (1 g 3×/d) plus TMP/SMX (320/1,600 mg 2×/d). 
Blood cultures grew B. pseudomallei until day 40. The 
patient died on day 60 from multiple organ failure.
Patient 3 was a 52-year-old man with a history 
of chronic alcoholism. He developed pneumonia in 
April 2017. Thoracic tomography showed an exca-
vated condensation of the right middle lobe, right 
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Melioidosis has been detected in the Caribbean, and 
an increasing number of cases has been reported in 
the past few decades, but only 2 cases were reported 
in Guadeloupe during the past 20 years. We describe 3 
more cases that occurred during 2016–2017 and exam-
ine arguments for increasing endemicity.
